Allay Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
39
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$57.5M
- Investors
-
19
Allay Therapeutics General Information
Description
Developer of sustained analgesic products designed to provide post-surgical pain management and recuperation for patients and physicians. The company's platform combines validated local analgesics and biopolymers in dissolvable candidates designed to deliver pain relief and address the drawbacks of opioids, enabling patients to get through the phase of recuperation in a simplified way.
Contact Information
Website
www.allaytx.comCorporate Office
- 2720 Zanker Road
- San Jose, CA 95134
- United States
Corporate Office
- 2720 Zanker Road
- San Jose, CA 95134
- United States
Allay Therapeutics Timeline
Allay Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series D) | 05-Jun-2025 | $57.5M | Completed | Clinical Trials - Phase 2 | ||
| 3. Later Stage VC (Series C) | 21-Dec-2023 | Completed | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC (Series B1) | 07-Feb-2019 | $26M | $30.4M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 09-Jan-2017 | $7M | $4.4M | Completed | Startup |
Allay Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B-1 | 14,191,717 | $0.001000 | $0.09 | $1.11 | $1.11 | 1x | $1.11 | 5.67% |
| Series A | 4,400,000 | $0.001000 | $0.08 | $1 | $1 | 1x | $1 | 1.76% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Allay Therapeutics Comparisons
Industry
Financing
Details
Allay Therapeutics Competitors (2)
One of Allay Therapeutics’s 2 competitors is Pacira BioSciences, a Formerly VC-backed company based in Tampa, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pacira BioSciences | Formerly VC-backed | Tampa, FL | ||||
| Vertex Pharmaceuticals | Formerly VC-backed | Boston, MA |
Allay Therapeutics Patents
Allay Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4794785-A1 | Carbocyclic and heterocyclic stat3 inhibitor compositions and methods | Pending | 10-Nov-2023 | ||
| WO-2025102082-A1 | Carbocyclic and heterocyclic stat3 inhibitor compositions and methods | Inactive | 10-Nov-2023 | ||
| EP-4795028-A1 | N-phenyl-3-(2,5-dioxopyrrolidin-1-yl)propanamide derivatives and similar compounds as dux4 inhibitors for the treatment of e.g. neuromuscular disorders | Pending | 20-Oct-2023 | ||
| WO-2025085878-A1 | N-phenyl-3-(2,5-dioxopyrrolidin-1-yl)propanamide derivatives and similar compounds as dux4 inhibitors for the treatment of e.g. neuromuscular disorders | Inactive | 20-Oct-2023 | ||
| WO-2024145662-A1 | 2-substituted thiazole and benzothiazole compositions and methods as dux4 inhibitors | Inactive | 30-Dec-2022 | C07D417/12 |
Allay Therapeutics Signals
Allay Therapeutics Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EDBI | Venture Capital | Minority | ||
| HSBC Innovation Banking | Corporation | Minority | ||
| Maruishi Pharmaceutical | Corporation | Minority | ||
| Nea | Venture Capital | Minority | ||
| SGInnovate | Corporate Venture Capital | Minority |
Allay Therapeutics FAQs
-
When was Allay Therapeutics founded?
Allay Therapeutics was founded in 2017.
-
Where is Allay Therapeutics headquartered?
Allay Therapeutics is headquartered in San Jose, CA.
-
What is the size of Allay Therapeutics?
Allay Therapeutics has 39 total employees.
-
What industry is Allay Therapeutics in?
Allay Therapeutics’s primary industry is Drug Discovery.
-
Is Allay Therapeutics a private or public company?
Allay Therapeutics is a Private company.
-
What is the current valuation of Allay Therapeutics?
The current valuation of Allay Therapeutics is .
-
What is Allay Therapeutics’s current revenue?
The current revenue for Allay Therapeutics is .
-
How much funding has Allay Therapeutics raised over time?
Allay Therapeutics has raised $175M.
-
Who are Allay Therapeutics’s investors?
EDBI, HSBC Innovation Banking, Maruishi Pharmaceutical, Nea, and SGInnovate are 5 of 19 investors who have invested in Allay Therapeutics.
-
Who are Allay Therapeutics’s competitors?
Pacira BioSciences and Vertex Pharmaceuticals are competitors of Allay Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process